These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 29147759)

  • 1. Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature.
    Mari A; Campi R; Tellini R; Gandaglia G; Albisinni S; Abufaraj M; Hatzichristodoulou G; Montorsi F; van Velthoven R; Carini M; Minervini A; Shariat SF
    World J Urol; 2018 Feb; 36(2):157-170. PubMed ID: 29147759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors.
    Honma I; Masumori N; Sato E; Takayanagi A; Takahashi A; Itoh N; Tamagawa M; Sato MA; Tsukamoto T
    Urology; 2004 Oct; 64(4):744-8. PubMed ID: 15491713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
    Dhar NB; Jones JS; Reuther AM; Dreicer R; Campbell SC; Sanii K; Klein EA
    BJU Int; 2008 Apr; 101(8):969-72. PubMed ID: 18005201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of clinical stage among patients with a complete pathologic response at radical cystectomy after neoadjuvant chemotherapy.
    Parker WP; Ho PL; Boorjian SA; Melquist JJ; Thapa P; Holzbeierlein JM; Frank I; Kamat AM; Lee EK
    World J Urol; 2016 Nov; 34(11):1561-1566. PubMed ID: 26943643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy.
    Abdi H; Pourmalek F; Gleave ME; So AI; Black PC
    World J Urol; 2016 Jan; 34(1):41-8. PubMed ID: 26621208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy.
    Mitra AP; Alemozaffar M; Harris BN; Schuckman AK; Skinner EC; Daneshmand S
    Urology; 2014 Dec; 84(6):1420-6. PubMed ID: 25306479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
    Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP
    J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience.
    Yafi FA; Aprikian AG; Fradet Y; Chin JL; Izawa J; Rendon R; Estey E; Fairey A; Cagiannos I; Lacombe L; Lattouf JB; Bell D; Saad F; Drachenberg D; Kassouf W
    BJU Int; 2012 Nov; 110(9):1317-23. PubMed ID: 22500588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
    Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
    J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study.
    Zehnder P; Studer UE; Skinner EC; Dorin RP; Cai J; Roth B; Miranda G; Birkhäuser F; Stein J; Burkhard FC; Daneshmand S; Thalmann GN; Gill IS; Skinner DG
    J Urol; 2011 Oct; 186(4):1261-8. PubMed ID: 21849183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
    Stein JP; Cai J; Groshen S; Skinner DG
    J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adjuvant radiotherapy for bladder cancer in patients with risk of locoregional recurrence: Who, what and how?].
    Sargos P; Larré S; Chapet O; Latorzeff I; Fléchon A; Roubaud G; Orré M; Belhomme S; Richaud P
    Cancer Radiother; 2017 Feb; 21(1):67-72. PubMed ID: 28187997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer.
    Larcher A; Sun M; Schiffmann J; Tian Z; Shariat SF; McCormack M; Saad F; Fossati N; Abdollah F; Briganti A; Buffi N; Graefen M; Guazzoni G; Montorsi F; Karakiewicz PI
    Eur J Surg Oncol; 2015 Mar; 41(3):353-60. PubMed ID: 25477269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy.
    Baumann BC; Guzzo TJ; He J; Keefe SM; Tucker K; Bekelman JE; Hwang WT; Vaughn DJ; Malkowicz SB; Christodouleas JP
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):81-8. PubMed ID: 22543204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic outcomes for lymph node-positive urothelial carcinoma patients treated with robot assisted radical cystectomy: with mean follow-up of 3.5 years.
    Mmeje CO; Nunez-Nateras R; Nielsen ME; Pruthi RS; Smith A; Wallen EM; Humphreys MR; Woods ME; Castle EP
    Urol Oncol; 2013 Nov; 31(8):1621-7. PubMed ID: 22534088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence patterns after open and robot-assisted radical cystectomy for bladder cancer.
    Nguyen DP; Al Hussein Al Awamlh B; Wu X; O'Malley P; Inoyatov IM; Ayangbesan A; Faltas BM; Christos PJ; Scherr DS
    Eur Urol; 2015 Sep; 68(3):399-405. PubMed ID: 25709026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
    Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
    Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.